Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 20,000 shares at $82.53 ($1.7M) on 2019-11-15, disclosed to the SEC on 2019-11-19.
Open-market sale of $1.7M NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.53 | 6,100 | $503K | 30.2% |
| 2 | $83.52 | 12,461 | $1.0M | 62.5% |
| 3 | $84.01 | 1,439 | $121K | 7.3% |
| Total | $83.25 avg | 20,000 | $1.7M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |